+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Eczema Therapeutics Market 2024-2028 - Product Thumbnail Image

Eczema Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 172 Pages
  • Global
From
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 326 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 387 Pages
  • Global
From
Cardiotonic Agents - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents - Global Strategic Business Report

  • Report
  • November 2025
  • 568 Pages
  • Global
From
Lisinopril - Global Strategic Business Report - Product Thumbnail Image

Lisinopril - Global Strategic Business Report

  • Report
  • November 2025
  • 476 Pages
  • Global
From
Long QT Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Long QT Syndrome Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 277 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 179 Pages
  • Global
From
Dyslipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 268 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 181 Pages
  • Global
From
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 413 Pages
  • Global
From
From
From
Cardiomyopathy Therapies - Global Strategic Business Report - Product Thumbnail Image

Cardiomyopathy Therapies - Global Strategic Business Report

  • Report
  • November 2025
  • 250 Pages
  • Global
From
From
mHealth Apps - Global Strategic Business Report - Product Thumbnail Image

mHealth Apps - Global Strategic Business Report

  • Report
  • November 2025
  • 239 Pages
  • Global
From
Loading Indicator